American Shared Hospital Services
AMSHealthcare·Medical Care Facilities·USA·Nano·AMEX·Nov 12 • 3:59 PM ET
1.09-0.09 (-7.63%)
2026-11-13 13:03 CET
Market cap
$7.25M
Revenue, TTM
30.87 USD m
Net income, TTM
-2.38 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-0.35
Price
AMS against its 20, 50 and 200-day averagesPatternshover a marker to name it
54.4% under the 52-week high of 2.39 on 12 Feb 2026. 52-week low 0.98 on 12 Nov 2026. Last 15 sessions, 38.0% high to low
Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average
Setup. RS line 0
CANSLIM 1 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 1 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15% — not on the tape: EPS Growth Next Year: High (>25%)
Quality 0 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); Current Ratio: Over 1 — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
AMS52-week range, 8% of the way up
0.982.39
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment and services to healthcare providers. It operates through the following segments: Leasing and Direct Patient Service. The Leasing segment focuses on the provision of radiation therapy through medical equipment leasing. The company was founded by Ernest A. Bates in 1977 and is headquartered in San Francisco, CA.
| Employees | 87 |
|---|---|
| IPO | Jul 03, 1984 |
| Beta | 0.28 |
| ATR, 14d | 0.07 |
| Rel volume | 0.00 |
| Short float | 0.26% |
| Insider own | 33.66% |
| Inst own | 7.51% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $7.25M |
| Enterprise Value | 20.99M |
| Income | -2.38M |
| Sales | 30.87M |
| Book / share | 3.40 |
| Cash / share | 1.43 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | Jun 28, 2007 |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 87 |
| IPO | Jul 03, 1984 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 0.23 |
| Price / book | 0.32 |
| Price / cash | 0.76 |
| Price / free cash flow | 2.05 |
| Value / cash profit | 7.80 |
| Value / sales | 0.68 |
| Quick Ratio | 0.77 |
| Current Ratio | 0.81 |
| Debt / equity | 0.91 |
| Long-term debt / equity | 0.18 |
| Options and short | No / Yes |
Earnings
| Earnings / share | -0.35 |
|---|---|
| Earnings next year | - |
| Earnings next quarter | 0.01 |
| Earnings this year | 39.13% |
| Earnings next year | - |
| Earnings growth, 5 years | - |
| Past earnings growth | - 27.12% |
| Past sales growth | 12.46% 9.50% |
| Earnings vs last year | 28.88% |
| Sales vs last year | 4.90% |
| Earnings vs last quarter | -3419.23% |
| Sales vs last quarter | 6.32% |
| Earnings | Nov 12 BMO |
| Surprise | -1000.00% -10.62% |
Ownership
| Insiders own | 33.66% |
|---|---|
| Insider trades | 35.48% |
| Institutions own | 7.51% |
| Institution trades | -28.67% |
| Return on assets | -4.23% |
| Return on equity | -10.08% |
| Return on capital | -8.72% |
| Gross Margin | 16.64% |
| Operating margin | -8.41% |
| Profit Margin | -7.70% |
| 20-day average | -11.58% |
| 50-day average | -18.34% |
| 200-day average | -30.67% |
Technical
| Shares out | 6.65M |
|---|---|
| Shares floating | 4.41M |
| Short / float | 0.26% |
| Short ratio | 0.99 |
| Short interest | 0.01M |
| 52-week high | 2.39 -54.4% |
| 52-week low | 0.98 +11.2% |
| Volatility | 7.10% 5.44% |
| Average range | 0.07 |
| Strength index | 28.64 |
| Market sensitivity | 0.28 |
| Relative volume | 0.00 |
| Avg Volume | 11.73K |
| Volume | 0 |
Performance
| Perf Week | -6.84% |
|---|---|
| Perf Month | -14.17% |
| Perf Quarter | -27.33% |
| Perf Half Y | -31.01% |
| Perf YTD | -48.34% |
| Perf Year | -47.60% |
| Perf 3Y | -50.90% |
| Perf 5Y | -60.07% |
| Perf 10Y | -66.46% |
| Recommendation | - |
| Target Price | 4.00 |
| Prev Close | 1.09 |
| Price | 1.09 |
| Change % | 0.00% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| CCM | Concord Medical Services ADR | 10.01M |
| ARAY | Accuray Inc | 9.24M |
| STLN | Starling Oncology Inc | 380.43M |
| AUNA | Auna SA | 338.24M |
| SGRY | Surgery Partners Inc | 3.42B |
| ITOC | iTonic Holdings Ltd | 16.24M |
| RDNT | Radnet Inc | 5.99B |
| GEHC | GE HealthCare Technologies Inc | 37.05B |
| CATX | Perspective Therapeutics Inc | 101.73M |
| VREX | Varex Imaging Corp | 775.81M |
Insider trading
1 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Stachowiak Raymond C | Executive Chairman | Jun 22 '26 | Buy | 2.28 | 586,468 | 1,337,147 | 586,468 | Jun 24 04:09 PM |
Held by
AUMNews
latest 14 of 200- American Shared Hospital Services Misses Badly As Growth Stalls, Though Cash Build Buys Time On The Balance Sheet (Earnings Whispers) -7.63%
- American Shared Hospital Services Reports Third Quarter and Nine-Month 2026 Financial Results (GlobeNewswire)
- American Shared Hospital Services Must Show Growth Can Fund A Strained Balance Sheet (Earnings Whispers)
- American Shared Hospital Services Announces Third Quarter 2026 Financial Results Conference Call (GlobeNewswire) +5.17%
- American Shared Hospital Services (AMS) (Q2 2026) Earnings Call Highlights: Strong Revenue ... (GuruFocus.com) -6.25%
- American Shared Hospital Services Reports Second Quarter and First Half 2026 Financial Results (GlobeNewswire)
- American Shared Hospital Services Announces Second Quarter 2026 Financial Results Conference Call (GlobeNewswire)
- American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on June 24, 2026 (GlobeNewswire)
- American Shared Hospital Services (AMS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) -5.95% -6.96%
- American Shared Hospital Services Reports First Quarter 2026 Financial Results (GlobeNewswire)
- American Shared Hospital Services Announces First Quarter 2026 Financial Results Conference Call (GlobeNewswire) -8.47%
- American Shared Hospital Services (AMS) Q4 2025 Earnings Call Highlights: Navigating Revenue ... (GuruFocus.com) -19.89% -6.90%
- American Shared Hospital Services Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
- American Shared Hospital Services Announces Fourth Quarter and Full Year Financial Results Conference Call (GlobeNewswire)
Quarterly earnings
2026Q3 EPS -0.090 missed 0.010, from 0.000 a year earlier. Sales 7.62 missed 8.53, from 7.17 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-12 08:30 | -0.090 | 0.010 | -0.092 | 7.62 | 8.53 | EPS -1000.0% · sales -10.6% | vs 2025Q3, year-ago quarter · EPS - · sales +6.3% | 1 | Open -9.32% vs SPY -0.77%. Close -7.63% vs SPY -0.35% |
| 2026Q2ended 2026-06-30 | 2026-08-13 08:30 | -0.070 | -0.020 | -0.075 | 8.43 | 7.56 | EPS +250.0% · sales +11.5% | vs 2025Q2, year-ago quarter · EPS +75.0% · sales +19.2% | 1 | Open +2.60% vs SPY +0.31%. Close +3.90% vs SPY +0.70% |
| 2026Q1ended 2026-03-31 | 2026-05-14 08:30 | -0.090 | -0.010 | -0.091 | 7.10 | 6.87 | EPS +800.0% · sales +3.3% | vs 2025Q1, year-ago quarter · EPS -10.0% · sales +16.2% | 1 | Open -2.98% vs SPY +0.18%. Close -5.95% vs SPY +0.79% |
| 2025Q4ended 2025-12-31 | 2026-03-31 08:30 | -0.090 | 0.020 | -0.094 | 7.73 | 8.78 | EPS -550.0% · sales -12.0% | vs 2024Q4, year-ago quarter · EPS - · sales -14.8% | 1 | Open -5.52% vs SPY +1.10%. Close -19.89% vs SPY +2.91% |
| 2025Q3ended 2025-09-30 | 2025-11-13 08:30 | 0.000 | - | -0.003 | 7.17 | - | EPS - · sales - | vs 2024Q3, year-ago quarter · EPS -100.0% · sales +2.5% | - | Open +3.85% vs SPY -0.42%. Close +7.69% vs SPY -1.66% |
| 2025Q2ended 2025-06-30 | 2025-08-13 08:30 | -0.040 | - | -0.043 | 7.07 | - | EPS - · sales - | vs 2024Q2, year-ago quarter · EPS -107.3% · sales +0.2% | - | Open +5.55% vs SPY +0.35%. Close +0.49% vs SPY +0.34% |
| 2025Q1ended 2025-03-31 | 2025-05-15 08:30 | -0.100 | - | -0.095 | 6.11 | - | EPS - · sales - | vs 2024Q1, year-ago quarter · EPS -600.0% · sales +17.2% | - | Open -2.68% vs SPY -0.35%. Close -10.07% vs SPY +0.49% |
| 2024Q4ended 2024-12-31 | 2025-04-04 12:00 | - | - | -0.200 | 9.07 | - | EPS - · sales - | vs 2023Q4, year-ago quarter · EPS - · sales +59.2% | - | Open -3.38% vs SPY -2.43%. Close +1.35% vs SPY -5.85% |
| 2024Q3ended 2024-09-30 | 2024-11-13 08:30 | -0.030 | 0.080 | -0.032 | 7.00 | 8.00 | EPS -137.5% · sales -12.5% | vs 2023Q3, year-ago quarter · EPS - · sales +36.3% | 1 | Open -7.17% vs SPY +0.08%. Close -11.21% vs SPY +0.05% |
| 2024Q2ended 2024-06-30 | 2024-08-14 16:30 | 0.550 | 0.070 | 0.547 | 7.06 | 6.00 | EPS +685.7% · sales +17.6% | vs 2023Q2, year-ago quarter · EPS - · sales +26.7% | 1 | Open -6.43% vs SPY +1.06%. Close -3.22% vs SPY +1.71% |
| 2024Q1ended 2024-03-31 | 2024-05-14 16:30 | 0.020 | 0.030 | 0.018 | 5.22 | 5.01 | EPS -33.3% · sales +4.1% | vs 2023Q1, year-ago quarter · EPS - · sales +5.9% | 1 | Open -6.82% vs SPY +0.48%. Close -2.56% vs SPY +1.24% |
| 2023Q4ended 2023-12-31 | 2024-03-27 16:30 | 0.060 | 0.020 | 0.063 | 5.70 | 5.19 | EPS +200.0% · sales +9.8% | vs 2022Q4, year-ago quarter · EPS - · sales +13.1% | 1 | Open +2.60% vs SPY +0.01%. Close +9.67% vs SPY -0.02% |
| 2023Q3ended 2023-09-30 | 2023-11-13 12:00 | - | - | 0.018 | 5.13 | - | EPS - · sales - | vs 2022Q3, year-ago quarter · EPS - · sales +6.3% | - | - |
| 2023Q2ended 2023-06-30 | 2023-08-14 16:30 | - | - | -0.018 | 5.57 | - | EPS - · sales - | vs 2022Q2, year-ago quarter · EPS - · sales +10.6% | - | - |
| 2023Q1ended 2023-03-31 | 2023-05-12 12:00 | - | - | 0.029 | 4.93 | - | EPS - · sales - | vs 2022Q1, year-ago quarter · EPS - · sales +1.6% | - | - |
| 2022Q4ended 2022-12-31 | 2023-03-24 12:00 | - | - | 0.039 | 5.04 | - | EPS - · sales - | vs 2021Q4, year-ago quarter · EPS - · sales +7.4% | - | - |
Annual earnings
2025FY EPS -0.230 missed -0.120, from 0.330 a year earlier. Sales 28.08 missed 29.13, from 28.34 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2026FYestimate | - | -0.140 | - | - | 32.68 | - |
| 2025FY | -0.230 | -0.120 | - | 28.08 | 29.13 | - |
| 2024FY | 0.330 | 0.530 | 0.326 | 28.34 | 26.97 | 9.67 |
| 2023FY | 0.100 | 0.050 | 0.095 | 21.33 | 20.81 | 23.79 |
| 2012FY | 0.010 | - | 0.010 | 17.05 | - | 109.00 |
| 2011FY | 0.110 | - | 0.110 | 22.22 | - | 9.91 |
| 2010FY | 0.010 | 0.029 | 0.010 | 16.68 | 30.11 | 109.00 |
Quarterly results
2026Q3 revenue 7.62, from 7.17 a year earlier. Operating margin -3.7%, from 0.7% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026Q4 E 0.01 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026Q4 | E | per share | 2026-11-12 | 0.01 | 0.0% |
| 2026Q4 | S | per share | 2026-11-12 | 8.63 | 0.0% |
| 2026FY | E | per share | 2026-11-03 | -0.14 | 0.0% |
| 2026Q3 | E | per share | 2026-11-03 | 0.01 | 0.0% |
| 2026FY | S | per share | 2026-11-03 | 32.68 | 0.0% |
| 2026Q3 | S | per share | 2026-11-03 | 8.53 | 0.0% |
| 2026Q2 | E | per share | 2026-05-14 | -0.02 | 0.0% |
| 2026Q2 | S | per share | 2026-05-14 | 7.56 | 0.0% |
| 2026Q1 | E | per share | 2026-04-07 | -0.01 | - |
| 2026Q1 | S | per share | 2026-04-07 | 6.87 | - |
| 2025FY | E | per share | 2026-02-24 | -0.12 | -140.0% |
| 2025Q4 | E | per share | 2026-02-24 | 0.02 | - |
| 2025FY | S | per share | 2026-02-24 | 29.13 | -8.3% |
| 2025Q4 | S | per share | 2026-02-24 | 8.78 | - |
| 2024FY | E | per share | 2025-02-25 | 0.53 | +1.9% |
| 2024Q4 | E | per share | 2025-01-27 | 0.01 | 0.0% |
| 2024Q4 | S | per share | 2025-01-27 | 7.70 | 0.0% |
| 2024FY | S | per share | 2024-11-13 | 26.97 | -0.1% |
| 2024Q3 | E | per share | 2024-11-04 | 0.08 | 0.0% |
| 2024Q3 | S | per share | 2024-08-15 | 8.00 | 0.0% |
| 2024Q2 | E | per share | 2024-07-29 | 0.07 | 0.0% |
| 2024Q2 | S | per share | 2024-07-29 | 6.00 | 0.0% |
| 2024Q1 | S | per share | 2024-04-02 | 5.01 | +0.8% |
| 2024Q1 | E | per share | 2024-03-28 | 0.03 | 0.0% |
| 2023FY | E | per share | 2024-02-29 | 0.05 | - |
| 2023FY | S | per share | 2024-02-29 | 20.81 | - |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | 0.327 | 0.175 | 0.111 | -1.142 | 0.032 | 0.211 | 0.095 | 0.326 | -0.235 | -0.3517 | - |
| Sales USD millions | 20 | 20 | 21 | 18 | 18 | 20 | 21 | 28 | 28 | 31 | - |
| Shares million shares | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | - | 7 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.032 | -0.2 | -0.095 | -0.043 | -0.003 | -0.094 | -0.091 | -0.075 | -0.092 |
| Sales USD millions | 7 | 9 | 6 | 7 | 7 | 8 | 7 | 8 | 8 |
| Shares million shares | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 30.87 | 28.08-0.9% | 28.34+32.9% | 21.32+7.9% | 19.75+12.0% | 17.63-1.2% | 17.84-13.4% | 20.61+4.6% | 19.71 |
| Cost of Goods Sold Incl. D&A | 25.73 | 23.04+19.6% | 19.26+59.6% | 12.07+5.7% | 11.42+3.6% | 11.02-18.7% | 13.55-1.5% | 13.76+11.9% | 12.30 |
| Gross Profit | 5.14 | 5.04-44.5% | 9.08-1.8% | 9.25+11.2% | 8.32+25.9% | 6.61+54.1% | 4.29-37.4% | 6.85-7.6% | 7.41 |
| Selling, General and Administrative Excl. Other | 7.73 | 7.06-3.3% | 7.30+5.3% | 6.93+36.1% | 5.09+15.2% | 4.42+3.8% | 4.26+6.8% | 3.99+1.8% | 3.92 |
| Other Operating Expense | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.60 | -2.01-212.9% | 1.78-23.3% | 2.32-28.4% | 3.24+47.9% | 2.19+10850.0% | 0.02-99.3% | 2.86-18.1% | 3.49 |
| Interest Expense | 1.40 | 1.57+4.7% | 1.50+35.1% | 1.11+37.0% | 0.81+9.5% | 0.74-30.2% | 1.06-19.7% | 1.32-19.0% | 1.63 |
| Unusual Expense | - | 0.00-100.0% | 3.08+227.7% | 0.94 | 0.00-100.0% | 0.51-94.0% | 8.43 | 0.00 | 0.00 |
| Net Income Before Taxes | -3.68 | -3.22-359.7% | 1.24+77.1% | 0.70-72.2% | 2.52+165.3% | 0.95 | -9.45-705.8% | 1.56-25.0% | 2.08 |
| Income Taxes | 0.19 | -0.49 | -0.29-167.4% | 0.43-55.2% | 0.96+255.6% | 0.27 | -1.74-1438.5% | 0.13-71.1% | 0.45 |
| Consolidated Net Income | -3.87 | -2.73-278.4% | 1.53+466.7% | 0.27-82.6% | 1.55+127.9% | 0.68 | -7.72-639.9% | 1.43-12.3% | 1.63 |
| Net Income From Continuing Operations | -2.38 | -1.55-170.8% | 2.19+259.0% | 0.61-54.1% | 1.33+600.0% | 0.19 | -7.06-1169.7% | 0.66-35.3% | 1.02 |
| Net Income | -2.38 | -1.55-170.8% | 2.19+259.0% | 0.61-54.1% | 1.33+600.0% | 0.19 | -7.06-1169.7% | 0.66-35.3% | 1.02 |
| EPS (Recurring) per share | -0.35 | -0.23-135.4% | 0.65+225.0% | 0.20-4.8% | 0.21+133.3% | 0.09 | -0.19-272.7% | 0.11-35.3% | 0.17 |
| EPS (Basic, Before Extraordinaries) per share | -0.35 | -0.23-167.6% | 0.34+240.0% | 0.10-52.4% | 0.21+600.0% | 0.03 | -1.14-1136.4% | 0.11-38.9% | 0.18 |
| EPS (Diluted) per share | -0.35 | -0.23-169.7% | 0.33+230.0% | 0.10-52.4% | 0.21+600.0% | 0.03 | -1.14-1136.4% | 0.11-35.3% | 0.17 |
| EBITDA | 2.69 | 3.70-53.5% | 7.95+6.1% | 7.49-10.4% | 8.36+11.8% | 7.48+2.7% | 7.28-29.1% | 10.27-0.4% | 10.31 |
| Non-Operating Income (Expense) | 0.32 | 0.37-90.8% | 4.04+839.5% | 0.43+377.8% | 0.09 | -0.00-100.0% | 0.01-50.0% | 0.02-90.9% | 0.22 |
| Other After Tax Adjustments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.27 | 0.32+10.3% | 0.29-6.5% | 0.31-3.1% | 0.32+3.2% | 0.31+40.9% | 0.22+29.4% | 0.17-5.6% | 0.18 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | 5.35 | 34.48 | 14.09 | 76.95 | - | 21.82 | 13.33 |
| Price To Sales Ratio ratio | - | 0.50 | 0.75 | 0.71 | 0.94 | 0.81 | 0.77 | 0.70 | 0.71 |
| Gross Margin % | 16.64 | 17.96 | 32.04 | 43.39 | 42.16 | 37.50 | 24.02 | 33.24 | 37.60 |
| Operating Margin % | -8.41 | -7.17 | 6.27 | 10.89 | 16.39 | 12.45 | 0.11 | 13.88 | 17.71 |
| Net Margin % | -7.70 | -5.53 | 7.71 | 2.86 | 6.73 | 1.10 | -39.57 | 3.20 | 5.19 |
| Shares Outstanding million shares | 6.65 | 6.58+2.5% | 6.42+1.9% | 6.30+1.9% | 6.18+2.1% | 6.05+4.5% | 5.79-0.5% | 5.82+1.9% | 5.71 |
| Market Capitalization | 7.25 | 7.25-64.6% | 20.48+36.6% | 14.99-16.9% | 18.03+29.6% | 13.91+8.8% | 12.79-11.2% | 14.40+5.9% | 13.60 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7.62+6.3% | 8.43+19.2% | 7.08+15.9% | 7.73-14.8% | 7.17+2.4% | 7.07+0.1% | 6.11+17.0% | 9.07+59.1% |
| Cost of Goods Sold Incl. D&A | 6.11+9.1% | 7.00+28.4% | 5.80+12.2% | 6.82+16.2% | 5.60-0.5% | 5.45+17.0% | 5.17+66.2% | 5.87+103.8% |
| Gross Profit | 1.52-3.2% | 1.43-11.7% | 1.28+36.2% | 0.91-71.6% | 1.57+14.6% | 1.62-32.5% | 0.94-55.5% | 3.20+13.5% |
| Selling, General and Administrative Excl. Other | 1.80+18.4% | 2.04+17.2% | 1.91+6.1% | 1.99+16.4% | 1.52-20.8% | 1.74-4.9% | 1.80-2.2% | 1.71-2.8% |
| Other Operating Expense | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -0.28-660.0% | -0.61 | -0.62 | -1.08-172.0% | 0.05 | -0.12-121.1% | -0.87-434.6% | 1.50+41.5% |
| Interest Expense | 0.48+23.1% | 0.30-30.2% | 0.30-30.2% | 0.32-25.6% | 0.39+14.7% | 0.43+10.3% | 0.43+22.9% | 0.43+48.3% |
| Unusual Expense | - | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 2.90+705.6% |
| Net Income Before Taxes | -0.74 | -0.86 | -0.87 | -1.21 | -0.28 | -0.50-113.4% | -1.24-6300.0% | -1.94-473.1% |
| Income Taxes | 0.16+220.0% | 0.14 | 0.09 | -0.20 | 0.05 | -0.02 | -0.32 | -0.07-120.6% |
| Consolidated Net Income | -0.91 | -1.00 | -0.96 | -1.01 | -0.33 | -0.48-112.7% | -0.91-1400.0% | -1.87-1138.9% |
| Net Income From Continuing Operations | -0.62 | -0.51 | -0.61 | -0.63 | -0.02 | -0.28-107.8% | -0.62-616.7% | -1.31-419.5% |
| Net Income | -0.62 | -0.51 | -0.61 | -0.63 | -0.02 | -0.28-107.8% | -0.62-616.7% | -1.31-419.5% |
| EPS (Recurring) per share | -0.09 | -0.07 | -0.09 | -0.09-181.8% | -0.00 | -0.04-107.0% | -0.10-600.0% | 0.11+10.0% |
| EPS (Basic, Before Extraordinaries) per share | -0.09 | -0.07 | -0.09 | -0.09 | -0.00 | -0.04-107.1% | -0.10-600.0% | -0.20-433.3% |
| EPS (Diluted) per share | -0.09 | -0.07 | -0.09 | -0.09 | -0.00 | -0.04-107.3% | -0.10-600.0% | -0.20-433.3% |
| EBITDA | 1.06-29.3% | 0.74-46.8% | 0.67+15.5% | 0.22-93.1% | 1.50+35.1% | 1.39-33.8% | 0.58-63.8% | 3.17+34.9% |
| Non-Operating Income (Expense) | 0.02-66.7% | 0.05+25.0% | 0.05-16.7% | 0.20 | 0.06-80.6% | 0.04-98.9% | 0.06-45.5% | -0.11-200.0% |
| Other After Tax Adjustments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.03-62.5% | 0.08-11.1% | 0.08+14.3% | 0.08+14.3% | 0.08+14.3% | 0.09+12.5% | 0.07-12.5% | 0.07-30.0% |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | - | - | 10.94 | 4.66 | 5.35 |
| Price To Sales Ratio ratio | - | 0.36 | 0.34 | 0.50 | 0.63 | 0.54 | 0.62 | 0.74 |
| Gross Margin % | 19.92 | 16.94 | 18.11 | 11.72 | 21.94 | 22.90 | 15.35 | 35.33 |
| Operating Margin % | -3.73 | -7.22 | -8.78 | -13.98 | 0.67 | -1.64 | -14.17 | 16.48 |
| Net Margin % | -8.13 | -6.10 | -8.64 | -8.17 | -0.24 | -3.96 | -10.23 | -14.42 |
| Shares Outstanding million shares | 6.65+2.2% | 6.62+2.2% | 6.60+2.3% | 6.58+2.5% | 6.51+1.9% | 6.48+1.9% | 6.45+1.9% | 6.42+1.9% |
| Market Capitalization | 7.25-60.2% | 10.47-32.6% | 9.52-46.7% | 13.81-32.6% | 18.23-6.0% | 15.54-23.1% | 17.85-4.0% | 20.48+36.6% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 3.71-67.1% | 11.28-18.3% | 13.81+10.9% | 12.45+50.7% | 8.26+90.8% | 4.33+143.3% | 1.78-0.6% | 1.79-28.4% | 2.50 |
| Short Term Receivables | 13.22+4.4% | 12.66+161.0% | 4.85+17.4% | 4.13-14.3% | 4.82+5.2% | 4.58-35.1% | 7.06+2.6% | 6.88+31.3% | 5.24 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.79-65.9% | 2.32+28.9% | 1.80-15.9% | 2.14+7.0% | 2.00+2.6% | 1.95+2.6% | 1.90+48.4% | 1.28+10.3% | 1.16 |
| Total Current Assets | 17.72-32.5% | 26.26+28.3% | 20.46+9.3% | 18.72+24.1% | 15.09+39.1% | 10.85+1.0% | 10.74+7.9% | 9.95+11.9% | 8.89 |
| Net Property, Plant & Equipment | 36.08+12.2% | 32.16+24.1% | 25.92+8.9% | 23.80-17.7% | 28.93-7.6% | 31.32-26.5% | 42.59-8.8% | 46.69-3.7% | 48.49 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 1.340.0% | 1.340.0% | 1.340.0% | 1.340.0% | 1.340.0% | 1.34 | - | - | - |
| Deferred Tax Assets | 1.31+15.9% | 1.13+66.2% | 0.68+58.1% | 0.43-25.9% | 0.58+286.7% | 0.15-75.0% | 0.60 | - | 2.10 |
| Other Assets | 0.34-22.7% | 0.440.0% | 0.44+388.9% | 0.09+28.6% | 0.07-50.0% | 0.14-69.6% | 0.46-46.5% | 0.86+8.9% | 0.79 |
| Total Assets | 56.79-7.4% | 61.33+25.6% | 48.84+10.0% | 44.39-3.5% | 46.01+5.0% | 43.80-19.5% | 54.38-5.4% | 57.50-4.6% | 60.27 |
| Short Term Debt Incl. Current Port. of LT Debt | 17.44+468.1% | 3.07-33.8% | 4.64+199.4% | 1.55+6.9% | 1.45-80.4% | 7.41+23.7% | 5.99-8.3% | 6.53-10.2% | 7.27 |
| Accounts Payable | 0.61-60.9% | 1.56+387.5% | 0.32+39.1% | 0.23-69.3% | 0.75+10.3% | 0.68+21.4% | 0.56+30.2% | 0.43+19.4% | 0.36 |
| Income Tax Payable | - | 0.00-100.0% | 1.23+373.1% | 0.26+160.0% | 0.10-73.0% | 0.37+184.6% | 0.13 | - | - |
| Other Current Liabilities | 5.39-6.7% | 5.78+25.9% | 4.59+46.2% | 3.14-12.8% | 3.60-8.2% | 3.92+154.5% | 1.54-38.6% | 2.51+81.9% | 1.38 |
| Total Current Liabilities | 23.44+125.4% | 10.40-3.5% | 10.78+108.5% | 5.17-12.2% | 5.89-52.4% | 12.38+50.8% | 8.21-13.3% | 9.47+5.1% | 9.01 |
| Long Term Debt | 4.23-77.5% | 18.84+70.7% | 11.04-10.0% | 12.26-16.5% | 14.68+109.7% | 7.00-36.1% | 10.96-19.6% | 13.64-14.1% | 15.87 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 1.43-30.6% | 2.06+178.4% | 0.74-40.8% | 1.25+19.0% | 1.05+87.5% | 0.56-82.0% | 3.11+5.1% | 2.96-40.9% | 5.01 |
| Other Liabilities | 0.00 | 0.00 | 0.00-100.0% | 0.07-50.0% | 0.14-33.3% | 0.21-27.6% | 0.29-23.7% | 0.38-24.0% | 0.50 |
| Total Liabilities | 29.10-7.0% | 31.30+38.7% | 22.56+20.3% | 18.76-13.8% | 21.77+8.0% | 20.15-10.7% | 22.57-14.7% | 26.45-13.0% | 30.39 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 24.03-4.6% | 25.18+11.3% | 22.62+4.6% | 21.62+8.7% | 19.89+3.2% | 19.27-26.0% | 26.03+3.7% | 25.10+5.2% | 23.86 |
| Total Shareholders Equity | 24.03-4.6% | 25.18+11.3% | 22.62+4.6% | 21.62+8.7% | 19.89+3.2% | 19.27-26.0% | 26.03+3.7% | 25.10+5.2% | 23.86 |
| Accumulated Minority Interest | 3.66-24.4% | 4.84+32.6% | 3.65-8.8% | 4.00-8.0% | 4.35-0.7% | 4.38-24.2% | 5.78-2.9% | 5.95-1.3% | 6.03 |
| Total Equity | 27.69-7.8% | 30.03+14.3% | 26.28+2.6% | 25.62+5.7% | 24.24+2.5% | 23.65-25.7% | 31.81+2.4% | 31.05+3.9% | 29.89 |
| Total Liabilities & Stockholders Equity | 56.79-7.4% | 61.33+25.6% | 48.84+10.0% | 44.39-3.5% | 46.01+5.0% | 43.80-19.5% | 54.38-5.4% | 57.50-4.6% | 60.27 |
| Book Value Per Share per share | 3.66-6.6% | 3.92+9.2% | 3.59+2.6% | 3.50+6.4% | 3.29-1.2% | 3.33-25.7% | 4.48+2.1% | 4.39+5.0% | 4.18 |
| Tangible Book Value Per Share per share | 3.45-7.0% | 3.71+9.8% | 3.38+3.0% | 3.28+6.8% | 3.07-1.0% | 3.10-30.8% | 4.48+2.1% | 4.39+5.0% | 4.18 |
| Full-Time Employees people | 87+102.3% | 43+38.7% | 31+6.9% | 29+45.0% | 20-4.8% | 21+50.0% | 14+55.6% | 90.0% | 9 |
| Price to Book Ratio ratio | 0.31 | 0.77 | 0.67 | 0.85 | 0.72 | 0.67 | 0.55 | 0.54 | 0.67 |
| Return on Assets % | -2.63 | 3.97 | 1.31 | 2.94 | 0.43 | -14.38 | 1.18 | 1.74 | 3.09 |
| Return on Equity % | -6.31 | 9.15 | 2.76 | 6.40 | 0.99 | -31.16 | 2.58 | 4.18 | 8.48 |
| Return on Invested Capital % | -5.49 | 4.97 | 1.81 | 3.92 | 0.56 | -26.87 | 1.78 | 2.64 | 4.84 |
| Quick Ratio ratio | 0.76 | 2.52 | 1.90 | 3.62 | 2.56 | 0.88 | 1.31 | 1.05 | 0.99 |
| Current Ratio ratio | 0.76 | 2.52 | 1.90 | 3.62 | 2.56 | 0.88 | 1.31 | 1.05 | 0.99 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | - | -2.73-278.4% | 1.53+466.7% | 0.27-82.6% | 1.55+127.9% | 0.68 | -7.72-639.9% | 1.43-12.3% | 1.63 |
| Depreciation | - | 5.71-7.5% | 6.17+19.3% | 5.17+1.0% | 5.12-3.0% | 5.28-27.3% | 7.26-2.0% | 7.41+8.7% | 6.82 |
| Deferred Taxes & Investment Tax Credit | - | -0.81 | -0.36 | -0.76-323.5% | 0.34+466.7% | 0.06 | -2.16 | -0.44-980.0% | 0.05 |
| Other Funds (Non Cash) | - | 0.83 | -0.23-117.2% | 1.34+162.7% | 0.51-53.6% | 1.10-87.1% | 8.55+1349.2% | 0.59+126.9% | 0.26 |
| Funds from Operations | - | 3.01-57.7% | 7.11+18.3% | 6.01-20.2% | 7.53+5.8% | 7.12+20.1% | 5.93-34.0% | 8.99+2.6% | 8.76 |
| Extraordinary Item | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | - | 0.09 | -6.95 | -0.29 | -0.30 | -0.85-122.3% | 3.82 | -0.94 | -0.70 |
| Income Taxes Payable | - | 0.00 | -1.23-226.8% | 0.97+506.3% | 0.16 | -0.23-227.8% | 0.18+38.5% | 0.13 | - |
| Cash from Operating Activities | - | 3.10+1723.5% | 0.17-97.0% | 5.72-21.0% | 7.24+15.5% | 6.27-35.6% | 9.74+21.0% | 8.05-0.1% | 8.06 |
| Capital Expenditures | - | -7.63 | -7.94 | -6.27 | -0.39 | -1.67 | -0.46 | -0.99 | -1.58 |
| Net Assets From Acquisitions | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.08 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | - | 0.01-98.9% | 0.87 | 0.00 | 0.00 | 0.00-100.0% | 0.15 | 0.00 | 0.00 |
| Purchase or Sale of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.05 |
| Cash from Investing Activities | - | -7.63 | -7.07 | -6.27 | -0.39 | -1.67 | -2.39 | -0.99 | -1.53 |
| Cash Dividends Paid | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | - | 0.00 | 0.00 | 0.00-100.0% | 0.010.0% | 0.01 | 0.00-100.0% | 0.04 | 0.00 |
| Repurchase of Common Pref Stock | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | - | 0.00 | 0.00 | 0.00-100.0% | 0.010.0% | 0.01 | 0.00-100.0% | 0.04 | 0.00 |
| Proceedsfrom Stock Options | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | - | -3.01-167.5% | 4.46+133.5% | 1.91 | -2.08-900.0% | 0.26 | -4.05 | -6.17 | -6.56 |
| Change in Long Term Debt | - | -3.01-143.2% | 6.96 | -0.39 | -2.03-378.1% | 0.73 | -3.53 | -6.12 | -6.56 |
| Issuance of Long Term Debt | - | 0.00-100.0% | 9.70+457.5% | 1.74 | 0.00-100.0% | 13.57+869.3% | 1.40 | 0.00 | 0.00 |
| Reduction of Long Term Debt | - | -3.01 | -2.73 | -2.13 | -2.03 | -12.85 | -4.92 | -6.12 | -6.56 |
| Net Financing Active Other Cash Flow | - | -0.02 | -0.10 | 0.00 | -0.57 | -0.92 | -0.76 | -0.94 | -0.69 |
| Other Financing Activities Uses | - | -0.02 | -0.10 | 0.00 | -0.57 | -0.92 | -0.76 | -0.94 | -0.69 |
| Cash from Financing Activities | - | -3.04-169.6% | 4.37+128.8% | 1.91 | -2.66 | -0.66 | -4.81 | -7.07 | -7.25 |
| Net Change in Cash | - | -7.56 | -2.53-287.4% | 1.35-67.8% | 4.19+6.3% | 3.94+54.5% | 2.55 | -0.01 | -0.71 |
| Free Cash Flow | - | -4.54 | -7.77 | -0.56-108.2% | 6.85+49.2% | 4.59-50.6% | 9.29+31.6% | 7.06+8.8% | 6.49 |
| Price to Free Cash Flow ratio | - | - | - | - | 2.70 | 3.13 | 1.48 | 2.05 | 2.15 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 9.48+77.5% | 6.76-40.3% | 5.22-54.6% | 3.71-67.1% | 5.34-62.1% | 11.33-21.8% | 11.49-11.9% | 11.28-18.3% |
| Short Term Receivables | - | 9.78-17.7% | 12.22+15.9% | 13.22+4.4% | 14.62+47.1% | 11.89+17.7% | 10.54+50.8% | 12.66+161.0% |
| Inventories | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | - | 0.83-31.4% | 0.83-51.7% | 0.79-65.9% | 0.63-62.9% | 1.21+14.2% | 1.72+28.4% | 2.32+28.9% |
| Total Current Assets | 19.06-7.4% | 17.37-28.9% | 18.27-23.0% | 17.72-32.5% | 20.59-19.9% | 24.43-4.7% | 23.74+11.1% | 26.26+28.3% |
| Net Property, Plant & Equipment | - | 33.47-10.4% | 34.78-8.0% | 36.08+12.2% | 37.34+4.3% | 37.34+11.0% | 37.81+40.4% | 32.16+24.1% |
| Total Investments and Advances | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | - | 1.340.0% | 1.340.0% | 1.340.0% | 1.340.0% | 1.340.0% | 1.340.0% | 1.340.0% |
| Deferred Tax Assets | - | - | - | 1.31+15.9% | - | - | - | 1.13+66.2% |
| Other Assets | - | 0.31-18.4% | 0.33-21.4% | 0.34-22.7% | 0.35-10.3% | 0.38+90.0% | 0.42-12.5% | 0.440.0% |
| Total Assets | 52.87-11.3% | 52.49-17.3% | 54.73-13.6% | 56.79-7.4% | 59.63-5.8% | 63.49+4.4% | 63.31+26.3% | 61.33+25.6% |
| Short Term Debt Incl. Current Port. of LT Debt | - | 16.38+9.5% | 17.00+226.3% | 17.44+468.1% | 11.68+40.9% | 14.96+107.2% | 5.21+1.2% | 3.07-33.8% |
| Accounts Payable | - | 0.58-28.4% | 1.08-12.2% | 0.61-60.9% | 1.11-38.0% | 0.81-5.8% | 1.23+355.6% | 1.56+387.5% |
| Income Tax Payable | - | - | - | - | - | - | - | 0.00-100.0% |
| Other Current Liabilities | 23.63+439.5% | 5.46+7.3% | 5.64-10.0% | 5.39-6.7% | 4.38-41.4% | 5.09-3.0% | 6.27+49.6% | 5.78+25.9% |
| Total Current Liabilities | 23.63+37.6% | 22.42+7.5% | 23.72+86.6% | 23.44+125.4% | 17.17-2.2% | 20.86+56.4% | 12.71+17.9% | 10.40-3.5% |
| Long Term Debt | - | 4.14-67.8% | 4.19-79.5% | 4.23-77.5% | 12.94+5.0% | 12.86-5.9% | 20.46+58.7% | 18.84+70.7% |
| Provision for Risks Charges | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | 0.12-87.0% | 0.12-87.0% | 1.43-30.6% | 0.92-41.0% | 0.92-37.4% | 0.92+1214.3% | 2.06+178.4% |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 23.63-23.8% | 26.68-23.0% | 28.02-17.8% | 29.10-7.0% | 31.03-1.3% | 34.65+21.7% | 34.10+43.6% | 31.30+38.7% |
| Non-Equity Reserves | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 22.61-8.0% | 23.11-5.6% | 23.52-4.6% | 24.03-4.6% | 24.57-7.0% | 24.48-7.8% | 24.65+7.9% | 25.18+11.3% |
| Total Shareholders Equity | 22.61-8.0% | 23.11-5.6% | 23.52-4.6% | 24.03-4.6% | 24.57-7.0% | 24.48-7.8% | 24.65+7.9% | 25.18+11.3% |
| Accumulated Minority Interest | - | 2.70-38.2% | 3.18-30.4% | 3.66-24.4% | 4.03-25.5% | 4.37-24.8% | 4.57+29.1% | 4.84+32.6% |
| Total Equity | 22.61-20.9% | 25.81-10.5% | 26.70-8.6% | 27.69-7.8% | 28.60-10.1% | 28.85-10.8% | 29.21+10.7% | 30.03+14.3% |
| Total Liabilities & Stockholders Equity | - | 52.49-17.3% | 54.73-13.6% | 56.79-7.4% | 59.63-5.8% | 63.49+4.4% | 63.31+26.3% | 61.33+25.6% |
| Book Value Per Share per share | 3.40-9.8% | 3.49-7.7% | 3.56-6.8% | 3.66-6.6% | 3.77-8.9% | 3.78-9.4% | 3.82+5.8% | 3.92+9.2% |
| Tangible Book Value Per Share per share | - | 3.29-7.8% | 3.36-6.9% | 3.45-7.0% | 3.57-8.9% | 3.57-9.8% | 3.61+6.2% | 3.71+9.8% |
| Full-Time Employees people | - | - | - | 87+102.3% | - | - | - | 43+38.7% |
| Price to Book Ratio ratio | 0.31 | 0.45 | 0.41 | 0.56 | 0.74 | 0.63 | 0.67 | 0.77 |
| Return on Assets % | -4.23 | -3.06 | -2.61 | -2.63 | -3.63 | -3.89 | 2.58 | 4.00 |
| Return on Equity % | -10.08 | -7.46 | -6.39 | -6.31 | -8.75 | -9.49 | 6.16 | 9.23 |
| Return on Invested Capital % | - | -1.89 | -2.21 | -2.23 | -0.05 | -0.75 | -1.39 | -2.97 |
| Quick Ratio ratio | - | 0.77 | 0.77 | 0.76 | 1.20 | 1.17 | 1.87 | 2.52 |
| Current Ratio ratio | 0.81 | 0.77 | 0.77 | 0.76 | 1.20 | 1.17 | 1.87 | 2.52 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | - | -1.00 | -0.96 | -1.01 | -0.33 | -0.48-112.7% | -0.91-1400.0% | -1.89-1150.0% |
| Depreciation | - | 1.35-10.6% | 1.29-11.0% | 1.30-22.2% | 1.45-11.6% | 1.51-0.7% | 1.45+9.0% | 1.67+29.5% |
| Other Funds (Non Cash) | - | 1.14+418.2% | 0.25+4.2% | 0.19-93.6% | 0.17 | 0.22 | 0.24+50.0% | 2.96+1309.5% |
| Funds from Operations | - | 1.48+18.4% | 0.58-25.6% | -0.32-114.5% | 1.30+4.8% | 1.25-40.8% | 0.78-50.0% | 2.21+140.2% |
| Extraordinary Item | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | - | 0.75 | 1.57-8.7% | -0.38 | 0.37 | -1.62 | 1.72 | -1.93 |
| Income Taxes Payable | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% |
| Cash from Operating Activities | - | 2.24 | 2.15-14.0% | -0.70-359.3% | 1.67+255.3% | -0.37-128.7% | 2.50 | 0.27 |
| Capital Expenditures | - | -0.06 | -0.04 | 1.98 | -3.70 | -1.90 | -4.01 | -4.66 |
| Net Assets From Acquisitions | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | - | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.01-75.0% | 0.29 |
| Purchase or Sale of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | - | -0.06 | -0.04 | 1.98 | -3.70 | -1.90 | -4.01 | -4.37 |
| Cash Dividends Paid | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | - | -0.64-130.3% | -0.47-127.3% | -2.91-325.6% | -3.93 | 2.11+108.9% | 1.72-26.5% | 1.29-43.9% |
| Change in Long Term Debt | - | -0.64 | -0.47 | -0.91-115.7% | -0.93 | -0.89 | -0.28-111.5% | 5.79+382.5% |
| Issuance of Long Term Debt | - | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00-100.0% | 7.09+307.5% |
| Reduction of Long Term Debt | - | -0.64 | -0.47 | -0.91 | -0.93 | -0.89 | -0.28 | -1.30 |
| Net Financing Active Other Cash Flow | - | 0.00 | -0.12 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | - | 0.00 | -0.12 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | - | -0.64-130.3% | -0.60-134.9% | -2.91-325.6% | -3.96 | 2.11+108.9% | 1.72-23.2% | 1.29-43.9% |
| Net Change in Cash | - | 1.54 | 1.51+586.4% | -1.63 | -5.99 | -0.16-111.1% | 0.22 | -2.80 |
| Free Cash Flow | - | 2.18 | 2.11 | 1.28 | -2.03 | -2.27-3342.9% | -1.51 | -4.39 |
| Price to Free Cash Flow ratio | - | 3.07 | - | - | - | - | - | - |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Equipment Sales | 0.16 | - | - | - |
| Patient Income | 12.56 | 15.53 | +23.7% | 55.3% |
| Rental Income from Medical Services | 15.63 | 12.55 | -19.7% | 44.7% |
| Total | 28.34 | 28.08 | -0.9% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Direct Patient Services | 12.56 | 15.53 | +23.7% | 55.3% |
| Medical Equipment Leasing | 15.78 | 12.55 | -20.5% | 44.7% |
| Total | 28.34 | 28.08 | -0.9% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.26% | 0.0M | 4.4M | 11.31K |
| 2026-10-15 | 0.14% | 0.0M | 4.4M | 12.73K |
| 2026-09-30 | 0.19% | 0.0M | 4.4M | 19.31K |
| 2026-09-15 | 0.12% | 0.0M | 4.4M | 81.43K |
| 2026-08-31 | 0.26% | 0.0M | 4.4M | 109.41K |
| 2026-08-14 | 1.06% | 0.0M | 4.4M | 123.20K |
| 2026-07-31 | 1.34% | 0.1M | 4.4M | 205.96K |
| 2026-07-15 | 1.19% | 0.1M | 4.4M | 258.70K |
| 2026-06-30 | 2.54% | 0.1M | 4.5M | 261.68K |
| 2026-06-15 | 2.47% | 0.1M | 4.4M | 196.54K |
| 2026-05-29 | 4.03% | 0.2M | 4.4M | 168.66K |
| 2026-05-15 | 3.23% | 0.1M | 3.7M | 157.85K |
| 2026-04-30 | 3.08% | 0.1M | 3.5M | 73.08K |
| 2026-04-15 | 0.06% | 0.0M | 3.5M | 21.87K |
| 2026-03-31 | 0.05% | 0.0M | 3.7M | 10.02K |
| 2026-03-13 | 0.02% | 0.0M | 3.7M | 8.22K |
| 2026-02-27 | 0.10% | 0.0M | 3.7M | 9.65K |
| 2026-02-13 | 0.29% | 0.0M | 3.7M | 9.86K |
| 2026-01-30 | 0.04% | 0.0M | 3.7M | 11.33K |
| 2026-01-15 | 0.03% | 0.0M | 3.7M | 12.49K |
Option chain
expiry 2026-11-13| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-12 | 8-K | Current report | 2026-11-12 | SEC |
| 2026-08-13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-13 | 8-K | Current report | 2026-08-13 | SEC |
| 2026-07-30 | SCHEDULE 13D/A | SEC | ||
| 2026-07-28 | 8-K | Current report | 2026-07-22 | SEC |
| 2026-07-24 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-22 | SEC |
| 2026-07-16 | 3 | Initial statement of beneficial ownership of securities | 2026-07-07 | SEC |
| 2026-07-13 | 8-K | Current report | 2026-07-07 | SEC |
| 2026-06-30 | 8-K | Current report | 2026-06-24 | SEC |
| 2026-06-25 | SCHEDULE 13D/A | SEC | ||
| 2026-06-24 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-22 | SEC |
| 2026-06-23 | SCHEDULE 13D/A | SEC | ||
| 2026-06-04 | 8-K | Current report | 2026-05-29 | SEC |
| 2026-05-14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
| 2026-05-14 | 8-K | Current report | 2026-05-14 | SEC |
| 2026-05-07 | DEFA14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2026-04-30 | ARS | Annual report to security holders. | 2025-12-31 | SEC |
| 2026-04-30 | DEFA14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2026-04-30 | DEF 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-06-24 | SEC |
| 2026-04-24 | 8-K | Current report | 2026-04-20 | SEC |
| 2026-04-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-26 | SEC |
| 2026-03-31 | 10-K | Annual report pursuant to Section 13 or 15(d) | 2025-12-31 | SEC |
| 2026-03-31 | 8-K | Current report | 2026-03-31 | SEC |
| 2026-03-19 | 8-K | Current report | 2026-03-13 | SEC |
| 2026-01-16 | 10-Q/A | 2025-09-30 | SEC | |
| 2026-01-02 | 8-K | Current report | 2025-12-27 | SEC |
| 2025-12-16 | SCHEDULE 13D/A | SEC | ||
| 2025-12-16 | 8-K | Current report | 2025-12-10 | SEC |
| 2025-12-09 | SCHEDULE 13D/A | SEC | ||
| 2025-11-14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-09-30 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 1.34M | 1 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| DIMENSIONAL FUND ADVISORS LP | 1.53% |
| LPL Financial LLC | 1.22% |
| STIFEL FINANCIAL CORP | 1.07% |
| RENAISSANCE TECHNOLOGIES LLC | 0.98% |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.84% |
| NewEdge Advisors, LLC | 0.45% |
| JAMES INVESTMENT RESEARCH, INC. | 0.45% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 0.39% |
| VANGUARD FIDUCIARY TRUST CO | 0.38% |
Funds
| Fund | % owned |
|---|---|
| EUPAC Fund | 156.45% |
| American Funds Fundamental Investors | 46.73% |
| New Perspective Fund | 32.54% |
| New Economy Fund | 27.77% |
| Growth Fund | 17.76% |
| BNY Mellon International Stock Fund | 14.47% |
| EUPAC Fund | 8.48% |
| Capital Income Builder | 6.94% |
| International Growth and Income Fund | 5.81% |
| American Funds International Vantage Fund | 5.50% |
OakChart. AMS. Cached 15 minutes. Terms
Some panels did not load: ratings.